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LETTER TO THE EDITOR
Finger-Prick Blood
Sampling for
Therapeutic Drug
Monitoring: Be Aware
of Skin Contamination
by Nebulized Drugs
To the Editor:
Over the past few years, the num-
ber of drugs for inhalation therapy and
nebulizer devices has rapidly expanded.1
Systemic exposure of inhalational drugs
is not only estimated during drug devel-
opment, but also used to monitor the ef-
fects of drug therapy, including toxicity.
New liquid chromatography–mass spec-
trometry techniques have facilitated
therapeutic drug monitoring using mini-
mal blood volumes and dried blood spot
methods taken by finger-prick sampling.
We recently performed a pharmaco-
kinetic study in children receiving intra-
venously administered salbutamol for
severe acute asthma.2 During data analy-
sis, we noticed 8 aberrantly high concen-
trations of salbutamol (Fig. 1) that could
not be attributed to the pharmacokinetic
profile of the drug, drug administration
errors, samples taken from the drug
administration line, clinical symptoms,
sample mix-ups, or other logistic errors.
All children were switched back to salbu-
tamol nebulization when the intravenous
administration was sufficiently reduced or
stopped. An alternative explanation was
contamination of the finger-prick sample
due to drug transfer from the skin to the
blood sample in the microtainer.
Salbutamol may be present on the fingers
as a consequence of holding the nebuliz-
ing device and the subsequent touching of
the mouth or the inner side of the device
during therapy. This contamination may
result in the overestimation of the true
blood concentration.3 Totally, 9 samples
(7%) were obtained through a finger prick
after switching back to nebulization, and 6
of these samples were found to have
aberrantly high drug concentrations.
Samples during nebulization before the
start of intravenous therapy were all taken
from an arterial line or central venous
catheter, instead of using a finger prick.
As our pharmacy department per-
forms regular therapeutic drug monitor-
ing for inhalational drugs, potential drug
contamination of the skin may seriously
impact interpretation of results and
patient care, for other drugs also. We
therefore designed a quality improvement
project that tested the hypothesis that
nebulized drugs may contaminate a pa-
tient’s fingers, leading to false high blood
concentrations from finger-prick samples.
The medical ethical review board granted
a waiver after reviewing the protocol. In
addition, the healthy volunteers provided
written informed consent.
METHODS
We performed 2 experiments: the
first was to examine proof-of-concept,
and the second was to investigate the
effects of mask holding and 2 cleaning
methods.
For the first experiment, a research
nurse prepared the salbutamol nebuliza-
tion equipment in accordance with the
protocol used in clinical care: 2-mL
NaCl 0.9% and 2-mL salbutamol 2 mg/
mL were combined in the ICU nebuliz-
ing system (Hudson ACI, Paediatric
aerosol mask combined with Hudson
Micro-Mist nebulizer). The research
nurse turned on the airflow. The pre-
pared salbutamol solution was nebulized
onto the hand of a salbutamol-free adult
volunteer. The hand was placed directly
at the opening of the nebulizing mask.
This volunteer was not involved in the
preparation of the nebulizer set-up and
did not touch the salbutamol solution.
After approximately 5 minutes, a finger-
prick sample of approximately 0.5 mL
was taken from the sprayed hand into
a microtainer.
The second experiment was per-
formed in 2 healthy adult volunteers.
The first volunteer held the nebulizer in
their left hand at the bottom, close to the
salbutamol reservoir, in the same man-
ner as older children. The second vol-
unteer held the nebulizer with their left
hand at the mask, in the same manner as
younger children. Both volunteers
sprayed the salbutamol from a distance
of 10 cm onto their right hand over
a period of 5 minutes. On their right
hand, one finger was not cleaned, one
finger was swabbed with alcohol to
mimic standard disinfection before
blood sampling, and one finger was
thoroughly cleaned with water and soap.
A finger-prick blood sample was taken
from each of these 3 fingers in addition to
one finger-prick sample from the left hand
holding the mask. All plasma samples
were stored at 280°C until analysis using
a validated liquid chromatography–mass
spectrometry method.
RESULTS
In the first experiment, spraying
salbutamol over the hand of the volun-
teer resulted in concentrations of .1000
mcg/L R-salbutamol and .1000 mcg/L
S-salbutamol. This was much higher
than the range of concentrations ana-
lyzed during intravenous salbutamol
infusion in children included in the trial
(R-salbutamol: median, 66 mcg/L;
S-salbutamol: median, 106 mcg/L), but
within the range of concentrations found
in the 8 outlier samples in the pilot study
(R-salbutamol range: 504–1918 mcg/L;
S-salbutamol range: 636–2018 mcg/L).
In the second experiment, the con-
centrations measured on the uncleaned
finger were 686 and 639 mcg/L, respec-
tively, for one volunteer, and 82 and
75 mcg/L for the other volunteer, respec-
tively, for R-salbutamol and S-salbutamol.
Cleaning with alcohol wipes resulted in
39%–56% lower salbutamol concentra-
tions for both volunteers (398 and 36
mcg/L R-salbutamol, 389 and 34 mcg/L
S-salbutamol). Cleaning with water
and soap decreased the concentrations
by 94%–100% (30 and 5 mcg/L
R-salbutamol, respectively; 29 mcg/L
and ,2 mcg/L S-salbutamol, respec-
tively). The concentrations measured
on the finger of the left hand were 8
mcg/L for R-salbutamol and 10 mcg/L
for S-salbutamol for the volunteer hold-
ing the system at the reservoir and 78
mcg/L for R-salbutamol and 56 mcg/LThe authors declare no conflict of interest.
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for S-salbutamol for the volunteer hold-
ing the system at the mask.
CONCLUSIONS
After nebulizing, skin contami-
nation can result in falsely elevated
plasma concentrations in finger-prick
blood samples. The contamination is
probably lesser on the hand holding the
system at the reservoir than the mask;
however, the fingers are still contami-
nated. The extreme high concentrations
may be the result of a longer nebulizing
period, or the child touching the
mouth or the inner side of the device.
We expect this contamination is
comparable in new dried-blood spot
techniques using finger-prick sam-
pling. Finger-prick blood sampling
should be used cautiously in therapeu-
tic drug monitoring and pharmacoki-
netic studies of nebulized drugs. To
overcome this problem, blood sam-
pling practices for these drugs should
be carefully considered to prevent
elevated levels and corresponding
biased conclusions. As a precaution,
wearing gloves on the sampling hand
or traditional venipuncture (if the sam-
pling place is covered during inhala-
tion) should be considered. Cleaning
techniques using both alcohol wipes or
water and soap result in unpredictable
contamination.
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FIGURE 1. Concentration–time profiles, including infusion rate for 2 patients in
which aberrantly high concentrations of salbutamol, were analyzed. The measured R-
salbutamol and S-salbutamol concentrations and infusion rates are presented in the
figure. Patient A restarted nebulization at 10 hours after inclusion, and patient B re-
started nebulization at 18 hours after inclusion.
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